Forcefield Therapeutics
UK - LondonBiotechnology
Focus: Forcefield Therapeutics is a UK-based biotech company focused on cardiomyocyte protective drugs for metabolic disease treatment. The company operates as a public-stage entity with a specialized focus on cardiac protection mechanisms.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Forcefield Therapeutics?
AI assessmentForcefield presents a specialized opportunity for candidates with cardiac metabolism expertise, but the lack of visible pipeline activity and hiring suggests a company in early preclinical or restructuring phase—due diligence on operational momentum is essential.
Why Work Here
- Focused therapeutic area (cardiomyocyte protection) offers deep scientific specialization and focused R&D direction
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Forcefield Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.